Clinical research making impacts at Middlemore
Clinical research plays a huge role in improving patient care and health outcomes. Middlemore Clinical Trials (MMCT) is giving health professionals at Counties Manukau Health more opportunities than ever to be involved in extraordinary innovation right on their doorstep.
Researchers seeking RSV vaccine trial participants
Pregnant women could help prevent future outbreaks of the Respiratory Syncytial Virus (RSV) that’s hospitalised scores of infants and young children by participating in one of Middlemore Clinical Trials, which is looking to develop one of the world’s first vaccines for RSV.
CM Health team’s trailblazing approach to combating rheumatic heart disease
Latest News 9 December 2020 | A Counties Manukau Health team led by paediatric infectious diseases specialist, Dr Rachel Webb, will develop and test an all-new approach for the early detection of rheumatic heart disease as part of a suite of new research to be carried out by some of…
Middlemore doctor leads COVID-19 treatment trial
Latest News 30 April 2020|A Counties Manukau Health doctor is leading a trial to find possible treatments for COVID-19. Middlemore clinical microbiologist and infectious diseases physician Dr Susan Morpeth is at the helm of the New Zealand arm of an Australasian study (ASCOT: the Australasian COVID-19 Trial).
Fisher and Paykel Healthcare announce clinical research partnership with CM Health
Latest news 9 December 2019|Fisher and Paykel Healthcare has announced a $1. 5 million partnership agreement with Counties Manukau Health (CM Health) to provide funding for clinical research at Middlemore Hospital.
Bladder cancer pilot producing results
Media release 5 March 2019 | A 12 month pilot programme testing for bladder cancer is achieving positive results for the Counties Manukau region. The Cx Bladder test is a non-invasive molecular based urine test for possible bladder cancer in patients’ presenting with blood in the urine (haematuria).